Literature DB >> 2765274

Effects of selective oral antimicrobial prophylaxis and systemic antibiotics on the fecal flora and fecal beta-aspartylglycine concentration in patients with acute leukemia.

W Bär1, G W Welling, E Kurrle.   

Abstract

The influence of selective oral antimicrobial prophylaxis (SOAP) and systemic antibiotic treatment (SAT) on the intestinal flora of fourteen granulocytopenic patients was investigated. For SOAP, patients received Cotrimoxazole, Polymyxin and Nystatin; Gentamicin, Ticarcillin and Cefuroxime were administered for SAT. Under SOAP, a complete elimination of Enterobacteriaceae and a marked reduction of yeasts and staphylococci was found. A reduction in the number of anaerobic species was also observed; however, the concentration of anaerobic bacteria remained constant. In contrast, additional systemic antibiotic treatment caused a significant reduction of aerobic as well as anaerobic bacteria, except for microorganisms pathogenic to neutropenic patients (i.e. Staphylococcus epidermidis and Candida sp.). The fecal concentration of beta-aspartylglycine was inversely correlated with the presence of anaerobic bacteria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2765274     DOI: 10.1111/j.1699-0463.1989.tb00466.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  3 in total

Review 1.  Selective decontamination in neutropenic patients.

Authors:  E Kurrle; T Schmeiser; W Kern
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

2.  Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice.

Authors:  G Samonis; E J Anaissie; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

3.  Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans.

Authors:  G Samonis; A Gikas; E J Anaissie; G Vrenzos; S Maraki; Y Tselentis; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.